Published Healthcare & Pharmaceuticals IBD Therapeutic Novel class of NF-κβ inhibitory bioactives identified from gut bacteria and developed into molecules that alleviates colitis in a murine model of inflammatory bowel disease. By The University of Queensland
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
